|
US3853893A
(en)
*
|
1973-04-02 |
1974-12-10 |
Squibb & Sons Inc |
Anthelmintic 5-(pyridyl)-3-(isothiocyanophenyl) oxadiazoles
|
|
HU177086B
(en)
*
|
1975-06-09 |
1981-07-28 |
Eszakmagyar Vegyimuevek |
Herbicide and fungicide preparation containing substituted 1,2,4-oxadiazolidin-3-one derivatives
|
|
JPS58150576A
(ja)
*
|
1982-03-03 |
1983-09-07 |
Sumitomo Chem Co Ltd |
新規な１，２，４−オキサジアゾ−ル誘導体
|
|
DE3247118A1
(de)
*
|
1982-12-20 |
1984-06-20 |
Cassella Ag, 6000 Frankfurt |
Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
|
KR100875222B1
(ko)
*
|
1999-08-19 |
2008-12-19 |
아스트라제네카 아베 |
헤테로폴리사이클릭 화합물 및 간접 글루타메이트 수용체길항제로서의 그들의 용도
|
|
EP1582519A3
(en)
*
|
1999-08-19 |
2005-12-21 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
US6660753B2
(en)
*
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
MXPA03007513A
(es)
*
|
2001-02-21 |
2004-07-30 |
Nps Pharma Inc |
Compuestos heteropoliciclicos y su uso como antagonistas del receptor metabotropico de glutamato.
|
|
US7074809B2
(en)
|
2002-08-09 |
2006-07-11 |
Astrazeneca Ab |
Compounds
|
|
US8178570B2
(en)
*
|
2003-04-09 |
2012-05-15 |
Exelixis, Inc. |
Tie-2 modulators and methods of use
|
|
AU2004240586A1
(en)
*
|
2003-05-15 |
2004-12-02 |
Merck & Co., Inc. |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as S1P receptor agonists
|
|
US20060189661A1
(en)
*
|
2003-11-03 |
2006-08-24 |
Wagenen Bradford V |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
WO2005060961A2
(en)
*
|
2003-12-18 |
2005-07-07 |
Astrazeneca Ab |
Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
|
|
JP4958560B2
(ja)
*
|
2003-12-24 |
2012-06-20 |
プロシディオン・リミテッド |
Ｇｐｃｒ受容体作動薬としてのヘテロ環誘導体
|
|
WO2005077368A2
(en)
*
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
US8017631B2
(en)
*
|
2005-04-26 |
2011-09-13 |
Neurosearch A/S |
Oxadiazole derivatives and their medical use
|
|
IL169855A
(en)
*
|
2005-07-25 |
2014-05-28 |
Elta Systems Ltd |
A system and method for locating a receiver location
|
|
PL1907382T3
(pl)
|
2005-07-26 |
2016-01-29 |
Bial Portela & Ca Sa |
Pochodne nitrokatecholowe jako inhibitory COMT
|
|
EP1845097A1
(en)
*
|
2006-04-10 |
2007-10-17 |
Portela & Ca., S.A. |
Oxadiazole derivatives as COMT inhibitors
|
|
PT2069336E
(pt)
*
|
2006-09-07 |
2013-03-07 |
Actelion Pharmaceuticals Ltd |
Derivados de piridin-4-ilo como agentes imunomoduladores
|
|
PL2069335T3
(pl)
*
|
2006-09-08 |
2013-05-31 |
Actelion Pharmaceuticals Ltd |
Pochodne pirydyn-3-ylu jako środki immunomodulujące
|
|
BRPI0721213B1
(pt)
*
|
2007-01-31 |
2021-11-09 |
Bial - Portela & Ca, S.A. |
Uso de nitrocatecóis substituídos, e embalagem
|
|
BRPI0808789A2
(pt)
*
|
2007-03-16 |
2014-08-12 |
Actelion Pharmaceuticals Ltd |
Compostos e composição farmacêutica de derivados aminopiridina e uso destes
|
|
PT2195311E
(pt)
*
|
2007-08-17 |
2011-05-25 |
Actelion Pharmaceuticals Ltd |
Derivados de piridina como moduladores do receptor s1p1/edg1
|
|
MX2010009043A
(es)
*
|
2008-02-28 |
2010-10-25 |
Bial Portela & Ca Sa |
Composicion farmaceutica para farmacos poco solubles.
|
|
EP2262799B1
(en)
*
|
2008-03-06 |
2012-07-04 |
Actelion Pharmaceuticals Ltd. |
Pyridine compounds
|
|
WO2009109872A1
(en)
*
|
2008-03-07 |
2009-09-11 |
Actelion Pharmaceuticals Ltd |
Pyridin-2-yl derivatives as immunomodulating agents
|
|
WO2009116882A1
(en)
|
2008-03-17 |
2009-09-24 |
Portela & Ca., S.A. |
Crystal forms of 5- [3- (2, 5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl) [1,2,3] oxadiazol-5-yl] -3-nit robenzene-1, 2-diol
|
|
EP3782991A1
(en)
|
2008-05-14 |
2021-02-24 |
The Scripps Research Institute |
Novel modulators of sphingosine phosphate receptors
|
|
CN105418598B
(zh)
|
2009-02-10 |
2019-05-17 |
孟山都技术有限公司 |
用于控制线虫的组合物和方法
|
|
PT2413912T
(pt)
|
2009-04-01 |
2019-06-11 |
Bial Portela & Ca Sa |
Formulações farmacêuticas compreendendo derivados de nitrocatecol e métodos para as produzir
|
|
BRPI1016132B8
(pt)
*
|
2009-04-01 |
2021-05-25 |
Bial Portela & Ca Sa |
composição, formulação farmacêutica, processo de obtenção de uma formulação farmacêutica estável
|
|
CA2767585C
(en)
|
2009-07-16 |
2017-09-26 |
Actelion Pharmaceuticals Ltd |
Pyridin-4-yl derivatives
|
|
MA34910B1
(fr)
|
2011-01-19 |
2014-02-01 |
Actelion Pharmaceuticals Ltd |
Dérivés de 2-methoxy-pyridin-4-yl
|
|
US20140045900A1
(en)
|
2011-02-11 |
2014-02-13 |
Bial-Portela & Ca, S.A. |
Administration regime for nitrocatechols
|
|
JP6456143B2
(ja)
|
2011-12-13 |
2019-01-23 |
ノヴィファーマ，エス．アー． |
カテコール−ｏ−メチル転移酵素阻害剤を調製するための中間体として有用な化学的化合物
|
|
US9232800B2
(en)
|
2013-02-15 |
2016-01-12 |
Monsanto Technology Llc |
3,5-disubstituted-4,5-dihydro-1,2,4-oxadiazoles and compositions and methods for controlling nematode pests
|
|
RU2017120184A
(ru)
|
2014-11-28 |
2018-12-28 |
БИАЛ - ПОРТЕЛА ЭНД Ка, С.А. |
Лекарства для замедления течения болезни паркинсона
|
|
PH12017502097B1
(en)
|
2015-05-20 |
2023-05-05 |
Idorsia Pharmaceuticals Ltd |
Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
|